MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Neural activity in pedunculopontine nucleus during sleep

    J. Maclean, J. Olaya, M. Liker, J. Nataraj, S. Javadzadeh No, SA. Seyyed Mousavi, T. Sanger (Orange, USA)

    Objective: Assess neural activity in various brain areas in sleep versus wakefulness in pediatric patients with movement disorders Background: Pedunculopontine nucleus (PPN) is believed to…
  • 2023 International Congress

    Parkinson’s Team Training is beneficial for new and established PD Centers

    E. Pollard, K. Lyons, D. Beran, C. Hunter, H. Cianci, E. Book (New York, USA)

    Objective: To determine if the Parkinson’s Foundation (PF) Parkinson’s disease (PD) Team Training (TT) empowers Parkinson’s interprofessional healthcare teams to make changes in their care…
  • 2023 International Congress

    Genetic diagnosis of parkinsonian phenotype of Machado Joseph Diseasep (SCA-3) presenting with dopa induced dyskinesia

    D. Chaudhari, A. Mishra, P. Renjen, K. Ahmad, N. Sahu (New Delhi, India)

    Objective: We report a rare type IV parkinsonian phenotype of MJD having a rare genetic mutation. SCA type 3 (SCA3), also known as Machado-Joseph disease…
  • 2023 International Congress

    The Healthy Brain Ageing (HeBA) Parkinson’s disease risk survey: Study design and methods

    C. Horlings, A. Garrido, C. Vega Moreno, S. Schade, T. Marques, P. Mahlknecht, C. Gomes, S. Ghosh, K. Rege, R. Rawal, C. Pauly, D. Mcintyre, K. Marini, K. Seppi, M. Marti, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krüger, B. Mollenhauer (Innsbruck, Austria)

    Objective: To present Healthy Brain Ageing (HeBA) – a European multi-centre population-based study on the prevalence and predictivity of risk factors for Parkinson´s Disease. Background:…
  • 2023 International Congress

    Сlinical neurological features of diabetic and non-diabetic patients with Parkinson’s disease.

    OK. Kasimova, DT. Akramova (Tashkent, Uzbekistan)

    Objective: In the last decade, attention has been focused on the relationship between neurodegeneration and abnormal insulin signaling in the central nervous system, insulin in…
  • 2023 International Congress

    Results from IRL790C005 – A Randomized, Double-Blind, Placebo-Controlled Phase IIb Study Evaluating the Efficacy of Mesdopetam on Daily On-Time without Troublesome Dyskinesia in Patients with Parkinson’s Disease

    A. Antonini, S. Waters, C. Sonesson, J. Landström, N. Waters, J. Tedroff (Padova, Italy)

    Objective: The objective of the Phase 2b-trial was to investigate efficacy and safety of three doses of Mesdopetam as adjunct treatment in patients with PD…
  • 2023 International Congress

    Making Parkinson’s care complete and global: an international survey of the “vitals” dashboard of Parkinson’s disease

    M. Qamar, C. Falup-Pecurariu, L. Batzu, A. Podlewska, S. Rota, N. Titova, V. Metta, I. Murasan, D. Ziemele, R. van Coller, J. Carr, G. Chung-Faye, L. Ungureanu, K. Ray Chaudhuri (London, United Kingdom)

    Objective: In this observational survey, we report on a multicentre dataset addressing whether such vitals are being routinely assessed. Background: Parkinson’s disease (PD), considered a…
  • 2023 International Congress

    Smartphone App-Based Stroop Test as a surrogate for impaired self-awareness in Parkinson’s disease.

    F. Thieken, S. Wattendorf, P. Korn, M. Kontz, O. Ataiy, P. Fischer, MO. Ashraf, V. Gross, D. Pedrosa, K. Sohrabi, L. Timmermann (Marburg, Germany)

    Objective: The aims of this study were to (i) develop age, sex and education stratified norm values of our smartphone app-based application of Stroop Test;…
  • 2023 International Congress

    White matter integrity in patients with PSP-RS and VaP: A TBSS Study

    K. Chatterjee, M. Tiwari, P. Basu, S. Choudhury, H. Kumar (Kolkata, India)

    Objective: The purpose of the present study was to compare alterations of brain white-matter microstructure and tissue integrity in PSP-RS and VaP patients using Diffusion…
  • 2023 International Congress

    The use of pallidal deep brain stimulation (GPi-DBS) to treat GNAO1 gene associated hyperkinetic syndromes

    A. Costa, D. Oliveira, M. Malaquias, L. Botelho, C. Silva, E. Cunha, V. Sá Pinto, N. Vila-Chã, I. Carrilho, M. Magalhães, A. Mendes (Porto, Portugal)

    Objective: To describe the clinical features and benefits of GPi-DBS approach in two patients with GNAO1 gene mutations to whom several episodes of choreo-dystonia exacerbations…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23862 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley